|
Al-Ahram Weekly
-
Egypt
4/27/2021 10:19:06 PM
Vaccine uptake among the public is worryingly low
|
|
World
-
International
4/27/2021 11:10:15 AM
The United States, France, Germany, Canada and the World Health Organization have all promised to rush supplies to India
|
|
Egypt
-
Politics
4/24/2021 2:30:00 PM
Egypt will receive 500,000 doses of the Chinese Sinopharm vaccine in late April and 4.5 million doses of AstraZeneca in May, Minister Zayed had said
|
|
Egypt
-
Politics
4/22/2021 2:32:00 PM
Minapharm, and its Berlin-based subsidiary PrioBioGen AG, and the RDIF plan to begin the technology transfer for the immediate manufacturing of the vaccine, with the rollout expected in the third quarter of 2021
|
|
World
-
Africa
4/22/2021 1:01:44 PM
African countries have struggled to secure enough COVID-19 vaccines to roll out mass immunisation campaigns
|
|
World
-
International
4/22/2021 11:48:38 AM
'EU states have to decide if they (will) participate. It is about fulfillment of deliveries by the end of the second quarter,' the official said
|
|
Egypt
-
Politics
4/20/2021 8:52:18 PM
Egypt has already received around 650,000 doses of the Chinese Sinopharm vaccine in the past months, which it currently administers with the AstraZeneca jab
|
|
World
-
Region
4/17/2021 5:33:08 PM
Those over 70 would get the AstraZeneca jab while the Russian Sputnik V vaccine would be administered to medical personnel and those aged 50-60, the National Centre for Disease Control said
|
|
World
-
International
4/16/2021 12:41:10 PM
The European Union is very unlikely to renew its Covid-19 vaccine contracts with pharmaceutical company AstraZeneca, a French minister said
|
|
World
-
International
4/15/2021 8:00:00 PM
Denmark this week became the first country to stop using AstraZeneca's vaccine altogether, as European officials investigate reports of rare blood clots combined with low platelet counts that have occurred in Europe and Britain
|
|
World
-
International
4/12/2021 11:08:41 AM
Authorities in Canberra changed their recommendation on Pfizer shots for under-50s on Thursday, after European regulators reiterated the possibility of links between the AstraZeneca shot and reports of rare cases of blood clots
|
|
World
-
International
4/11/2021 10:07:53 PM
AstraZeneca had a positive meeting with the European Commission last week, after an Italian newspaper said the group had not replied to an EU letter of complaint over COVID-19 vaccines within a 20-day deadline
|
|
Life & Style
-
Health
4/9/2021 8:04:54 PM
Johnson & Johnson said it was aware of the rare reports of blood clots in individuals given its COVID-19 vaccine, and was working with regulators to assess the data and provide relevant information
|
|
World
-
Africa
4/8/2021 7:57:21 PM
John Nkengasong, head of the Africa CDC said the main reason was to avoid duplicating COVAX's efforts by the World Health Organization-backed COVAX facility, which will continue to supply AstraZeneca to Africa
|
|
Egypt
-
Politics
4/8/2021 7:04:30 PM
Egypt will also receive additional doses of the Chinese Sinopharm vaccine in the coming days, which the minister estimated at up to one million doses.
|
|
World
-
International
4/8/2021 12:57:04 PM
Australia has been one of the world's most successful countries in containing the spread of Covid-19, with fewer than 30,000 cases and 1,000 deaths for a population of 25 million
|
|
World
-
International
4/7/2021 7:36:16 PM
The European Medicines Agency (EMA) said Wednesday that blood clots should be listed as a 'very rare' side effect, encouraging countries to continue its use
|
|
World
-
International
4/6/2021 7:31:00 PM
A senior official at Europe's medicines regulator has said there is a clear "association" between AstraZeneca's COVID-19 vaccine and very rare blood clots in the brain, though the direct cause of the clots is still unknown
|
|
World
-
International
4/3/2021 3:34:15 PM
The Medicines and Healthcare Regulatory Agency, or MHRA, said it wasn't clear if the shots are causing the clots, and that its ‘rigorous review into the U.K. reports of rare and specific types of blood clots is ongoing’
|
|
World
-
International
4/1/2021 10:09:30 PM
'Until the appropriate data is available, STIKO recommends for people under 60 years old that instead of the second AstraZeneca dose, a dose of an mRNA-vaccine should be given 12 weeks after the first vaccine,' STIKO said.
|